Prognostic factors and outcomes for osteosarcoma: an international collaboration.

[1]  Paul A Meyers,et al.  Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  S. Ferrari,et al.  Local recurrence and local control of non‐metastatic osteosarcoma of the extremities: A 27‐year experience in a single institution , 2007, Journal of surgical oncology.

[3]  D. Jeon,et al.  Time Dependency of Prognostic Factors in Patients with Stage II Osteosarcomas , 2007, Clinical orthopaedics and related research.

[4]  D. Vanel,et al.  SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients. , 2007, European journal of cancer.

[5]  M. Hicks,et al.  Clinicopathologic features of osteosarcoma in patients with Rothmund-Thomson syndrome. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  M. van Glabbeke,et al.  Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup. , 2007, Journal of the National Cancer Institute.

[7]  A. Petrilli,et al.  Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  H J Mankin,et al.  Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. , 2005, The Journal of bone and joint surgery. American volume.

[9]  E. Kleinerman,et al.  Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  M. Gebhardt,et al.  Biology and therapeutic advances for pediatric osteosarcoma. , 2004, The oncologist.

[11]  M. Link,et al.  Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  R. Grimer,et al.  Comparison of the Outcome of Conventional Osteosarcoma at Two Specialist International Orthopaedic Oncology Centres , 2003, Sarcoma.

[13]  E. van Marck,et al.  Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup. , 2002, European journal of cancer.

[14]  J. Ioannidis,et al.  Comparison of evidence of treatment effects in randomized and nonrandomized studies. , 2001, JAMA.

[15]  H. Yamamoto,et al.  High incidence of SV40-like sequences detection in tumour and peripheral blood cells of Japanese osteosarcoma patients , 2000, British Journal of Cancer.

[16]  R. Souhami,et al.  Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup , 1997, The Lancet.

[17]  N. Jaffe,et al.  Tumor size and prognosis in aggressively treated osteosarcoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  R. Weichselbaum,et al.  Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. , 1992, The New England journal of medicine.

[19]  H. Mouridsen,et al.  Prognostic factors in osteosarcomas. A regression analysis , 1988, Cancer.

[20]  M. Krailo,et al.  The relationship of various aspects of surgical management to outcome in childhood nonmetastatic osteosarcoma: a report from the Childrens Cancer Study Group. , 1988, Journal of pediatric surgery.

[21]  Stephen H. Friend,et al.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma , 1986, Nature.

[22]  G. Delling,et al.  [Determination of the degree of morphological regression following chemotherapy in malignant bone tumors]. , 1983, Der Pathologe.

[23]  G. Rosen,et al.  Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy , 1982, Cancer.

[24]  D. Dahlin.  Prognostic factors in osteosarcoma. , 1980, International journal of radiation oncology, biology, physics.

[25]  C. H. Price.  Primary bone-forming tumours and their relationship to skeletal growth. , 1958, The Journal of bone and joint surgery. British volume.

[26]  C. Beauchamp.  Osteosarcoma, Chondrosarcoma, and Ewing's Sarcoma: National Cancer Data Base Report , 2008 .

[27]  M. Simon,et al.  Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. 1986. , 2005, The Journal of bone and joint surgery. American volume.

[28]  W. Winkelmann,et al.  Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  W. Winkelmann,et al.  Limb salvage and outcome of osteosarcoma. The University of Muenster experience. , 1999, Clinical orthopaedics and related research.

[30]  W. Winkelmann,et al.  Limb Salvage and Outcome of Osteosarcoma , 1999 .

[31]  C. Silfverswärd,et al.  The age of osteosarcoma patients is increasing. An epidemiological study of osteosarcoma in Sweden 1971 to 1984. , 1990, The Journal of bone and joint surgery. British volume.

[32]  W. den Otter,et al.  Bone sarcomas linked to radiotherapy and chemotherapy in children. , 1988, The New England journal of medicine.

[33]  M. B. Coventry,et al.  OSTEOGENIC SARCOMA: A STUDY OF SIX HUNDRED CASES. , 1967 .